S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.80 (+-0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.80 (+-0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.80 (+-0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.80 (+-0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
NASDAQ:FONR

FONAR (FONR) Stock Price, News & Analysis

$21.57
-0.22 (-1.01%)
(As of 09:34 AM ET)
Today's Range
$21.57
$21.71
50-Day Range
$19.07
$23.24
52-Week Range
$12.13
$24.05
Volume
714 shs
Average Volume
18,738 shs
Market Capitalization
$136.54 million
P/E Ratio
11.72
Dividend Yield
N/A
Price Target
N/A
FONR stock logo

About FONAR Stock (NASDAQ:FONR)

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

FONR Stock Price History

FONR Stock News Headlines

Your $200 account credit is about to expire
Update to MarketBeat All Access and Save $300 on Your Annual Subscription
Fonar Corp.
Fonar: Fiscal Q2 Earnings Snapshot
the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
Fonar Corp FONR
2024 Strategies: Buy or Hold for 3 Medical Stocks?
Holiday Outlook: 3 Medical Stocks to Consider Buying
Fonar GAAP EPS of $0.59, revenue of $25.84M
Pleasing Signs As A Number Of Insiders Buy FONAR Stock
Back Into FONAR Corporation
Fonar Shares Drop on Volume Spike
See More Headlines
Receive FONR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FONAR and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2024
Today
3/28/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:FONR
Employees
561
Year Founded
N/A

Profitability

Net Income
$9.38 million
Pretax Margin
19.92%

Debt

Sales & Book Value

Annual Sales
$98.64 million
Cash Flow
$2.79 per share
Book Value
$23.07 per share

Miscellaneous

Free Float
5,785,000
Market Cap
$137.93 million
Optionable
Not Optionable
Beta
1.12
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

FONR Stock Analysis - Frequently Asked Questions

How have FONR shares performed in 2024?

FONAR's stock was trading at $19.56 at the beginning of the year. Since then, FONR stock has increased by 11.4% and is now trading at $21.79.
View the best growth stocks for 2024 here
.

Are investors shorting FONAR?

FONAR saw a increase in short interest in March. As of March 15th, there was short interest totaling 9,900 shares, an increase of 20.7% from the February 29th total of 8,200 shares. Based on an average daily trading volume, of 18,500 shares, the short-interest ratio is currently 0.5 days. Currently, 0.2% of the company's shares are sold short.
View FONAR's Short Interest
.

When is FONAR's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our FONR earnings forecast
.

How were FONAR's earnings last quarter?

FONAR Co. (NASDAQ:FONR) released its earnings results on Wednesday, February, 14th. The medical equipment provider reported $0.54 earnings per share for the quarter. The medical equipment provider had revenue of $25.39 million for the quarter. FONAR had a net margin of 12.63% and a trailing twelve-month return on equity of 8.47%.

What other stocks do shareholders of FONAR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FONAR investors own include Gilead Sciences (GILD), Amarin (AMRN), CRISPR Therapeutics (CRSP), Exelixis (EXEL), Pfizer (PFE), Bausch Health Companies (BHC), Incyte (INCY), Jazz Pharmaceuticals (JAZZ), Lannett (LCI) and Madrigal Pharmaceuticals (MDGL).

Who are FONAR's major shareholders?

FONAR's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (6.12%), Vanguard Group Inc. (6.05%), Vanguard Group Inc. (6.17%), Acuitas Investments LLC (3.39%), LSV Asset Management (1.82%) and Bridgeway Capital Management LLC (1.17%). Insiders that own company stock include Luciano B Bonanni and Timothy Raymond Damadian.
View institutional ownership trends
.

How do I buy shares of FONAR?

Shares of FONR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FONR) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners